Correction to: Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial

W Poon¹, C Matula², P E Vos³, D F Muresanu^{4

5}, N von Steinbüchel⁶, K von Wild⁷, V Hömberg⁸, E Wang⁹, T M C Lee¹⁰, S Strilciuc^{11

12}, J C Vester¹³

Affiliations

¹ Division of Neurosurgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
² Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
³ Department of Neurology, Slingeland Hospital, Doetinchem, The Netherlands.
⁴ Department of Clinical Neurosciences, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. dafinm@ssnn.ro.
⁵ RoNeuro Institute for Neurological Research and Diagnostic, No. 37 Mircea Eliade Street, 400364, Cluj-Napoca, Romania. dafinm@ssnn.ro.
⁶ Institute of Medical Psychology and Medical Sociology, University Medical Centre Göttingen, Göttingen, Germany.
⁷ Medical Faculty, Westphalia Wilhelm's University, Münster, Germany.
⁸ Department of Neurology, SRH Gesundheitszentrum Bad Wimpfen GmbH, Bad Wimpfen, Germany.
⁹ Department of Neurosurgery, National Neuroscience Institute, Singapore, Singapore.
¹⁰ State Key Laboratory of Brain and Cognitive Sciences and Laboratory of Neuropsychology, The University of Hong Kong, Pokfulam, Hong Kong, China.
¹¹ Department of Clinical Neurosciences, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
¹² RoNeuro Institute for Neurological Research and Diagnostic, No. 37 Mircea Eliade Street, 400364, Cluj-Napoca, Romania.
¹³ Department of Biometry and Clinical Research, idv Data Analysis and Study Planning, Krailling, Germany.

Published Erratum

W Poon et al. Neurol Sci. 2020 Mar.

. 2020 Mar;41(3):733.

doi: 10.1007/s10072-019-04149-y.

W Poon¹, C Matula², P E Vos³, D F Muresanu^{4

5}, N von Steinbüchel⁶, K von Wild⁷, V Hömberg⁸, E Wang⁹, T M C Lee¹⁰, S Strilciuc^{11

12}, J C Vester¹³

¹ Division of Neurosurgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
² Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
³ Department of Neurology, Slingeland Hospital, Doetinchem, The Netherlands.
⁴ Department of Clinical Neurosciences, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. dafinm@ssnn.ro.
⁵ RoNeuro Institute for Neurological Research and Diagnostic, No. 37 Mircea Eliade Street, 400364, Cluj-Napoca, Romania. dafinm@ssnn.ro.
⁶ Institute of Medical Psychology and Medical Sociology, University Medical Centre Göttingen, Göttingen, Germany.
⁷ Medical Faculty, Westphalia Wilhelm's University, Münster, Germany.
⁸ Department of Neurology, SRH Gesundheitszentrum Bad Wimpfen GmbH, Bad Wimpfen, Germany.
⁹ Department of Neurosurgery, National Neuroscience Institute, Singapore, Singapore.
¹⁰ State Key Laboratory of Brain and Cognitive Sciences and Laboratory of Neuropsychology, The University of Hong Kong, Pokfulam, Hong Kong, China.
¹¹ Department of Clinical Neurosciences, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
¹² RoNeuro Institute for Neurological Research and Diagnostic, No. 37 Mircea Eliade Street, 400364, Cluj-Napoca, Romania.
¹³ Department of Biometry and Clinical Research, idv Data Analysis and Study Planning, Krailling, Germany.

Abstract

The above article was published online with incorrect abbreviations in Figures 2 and 3 last sentence of the legend. HDA should be corrected to HADS.

Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial.
Poon W, Matula C, Vos PE, Muresanu DF, von Steinbüchel N, von Wild K, Hömberg V, Wang E, Lee TMC, Strilciuc S, Vester JC. Poon W, et al. Neurol Sci. 2020 Feb;41(2):281-293. doi: 10.1007/s10072-019-04053-5. Epub 2019 Sep 7. Neurol Sci. 2020. PMID: 31494820 Clinical Trial.